Agenus Selling General Administrative vs Operating Income Analysis

AGEN Stock

USD 11.69 3.39 40.84%

Agenus financial indicator trend analysis is way more than just evaluating Agenus Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Agenus Inc is a good investment. Please check the relationship between Agenus Selling General Administrative and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Selling General Administrative vs Operating Income

Selling General Administrative vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Agenus Inc Selling General Administrative account and Operating Income. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Agenus' Selling General Administrative and Operating Income is -0.56. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Operating Income in the same time period over historical financial statements of Agenus Inc, assuming nothing else is changed. The correlation between historical values of Agenus' Selling General Administrative and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Agenus Inc are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Selling General Administrative i.e., Agenus' Selling General Administrative and Operating Income go up and down completely randomly.

Correlation Coefficient

-0.56

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Selling General Administrative

Operating Income

Operating Income is the amount of profit realized from Agenus Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Agenus Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Agenus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Agenus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

At this time, Agenus' Selling General Administrative is very stable compared to the past year. As of the 28th of April 2024, Issuance Of Capital Stock is likely to grow to about 136.4 M, while Sales General And Administrative To Revenue is likely to drop 0.48.

Agenus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.49	0.78	0.81	-0.16	0.83	-0.05	-0.8	0.78	0.85	0.88	0.85	0.86	-0.21	0.84	0.7	0.59	0.62	0.84	0.83	0.89	0.39	-0.21	0.72	0.24	-0.08
Short Long Term Debt Total	0.49		0.02	0.74	-0.33	0.73	0.83	-0.65	0.81	0.07	0.75	0.33	0.08	-0.19	0.77	0.14	0.89	0.38	0.55	0.73	0.13	0.93	-0.18	0.39	-0.12	0.17
Other Current Liab	0.78	0.02		0.61	-0.39	0.59	-0.38	-0.7	0.48	0.71	0.64	0.7	0.72	-0.24	0.59	0.9	0.19	0.7	0.81	0.56	0.76	-0.04	-0.24	0.77	0.44	-0.22
Total Current Liabilities	0.81	0.74	0.61		-0.57	0.96	0.42	-0.94	0.97	0.4	0.96	0.7	0.42	-0.22	0.99	0.6	0.88	0.65	0.92	0.94	0.48	0.76	-0.21	0.87	0.25	-0.28
Total Stockholder Equity	-0.16	-0.33	-0.39	-0.57		-0.39	-0.41	0.64	-0.46	0.22	-0.44	-0.1	0.21	0.31	-0.5	-0.6	-0.41	-0.58	-0.66	-0.32	0.13	-0.4	0.31	-0.71	-0.27	0.21
Property Plant And Equipment Net	0.83	0.73	0.59	0.96	-0.39		0.4	-0.88	0.97	0.43	0.98	0.68	0.45	-0.16	0.97	0.49	0.87	0.57	0.84	0.99	0.5	0.73	-0.15	0.75	0.2	-0.28
Net Debt	-0.05	0.83	-0.38	0.42	-0.41	0.4		-0.32	0.51	-0.5	0.37	-0.15	-0.49	-0.1	0.42	-0.2	0.69	0.11	0.18	0.38	-0.44	0.85	-0.09	0.1	-0.24	0.13
Retained Earnings	-0.8	-0.65	-0.7	-0.94	0.64	-0.88	-0.32		-0.89	-0.43	-0.93	-0.7	-0.45	0.49	-0.94	-0.75	-0.74	-0.84	-0.96	-0.85	-0.52	-0.62	0.49	-0.88	-0.23	0.16
Accounts Payable	0.78	0.81	0.48	0.97	-0.46	0.97	0.51	-0.89		0.35	0.95	0.66	0.37	-0.17	0.98	0.45	0.94	0.56	0.83	0.97	0.42	0.84	-0.17	0.78	0.15	-0.29
Cash	0.85	0.07	0.71	0.4	0.22	0.43	-0.5	-0.43	0.35		0.5	0.78	1.0	-0.12	0.44	0.59	0.14	0.41	0.53	0.45	0.99	-0.07	-0.12	0.42	0.24	0.05
Non Current Assets Total	0.88	0.75	0.64	0.96	-0.44	0.98	0.37	-0.93	0.95	0.5		0.69	0.52	-0.24	0.98	0.61	0.83	0.67	0.9	0.96	0.57	0.7	-0.24	0.78	0.16	-0.13
Non Currrent Assets Other	0.85	0.33	0.7	0.7	-0.1	0.68	-0.15	-0.7	0.66	0.78	0.69		0.79	-0.22	0.71	0.57	0.51	0.58	0.69	0.71	0.81	0.33	-0.22	0.66	0.38	-0.28
Cash And Short Term Investments	0.86	0.08	0.72	0.42	0.21	0.45	-0.49	-0.45	0.37	1.0	0.52	0.79		-0.12	0.46	0.58	0.16	0.41	0.54	0.48	0.99	-0.05	-0.12	0.44	0.24	0.03
Common Stock Total Equity	-0.21	-0.19	-0.24	-0.22	0.31	-0.16	-0.1	0.49	-0.17	-0.12	-0.24	-0.22	-0.12		-0.26	-0.37	-0.06	-0.67	-0.33	-0.14	-0.15	-0.08	1.0	-0.26	0.13	-0.21
Common Stock Shares Outstanding	0.84	0.77	0.59	0.99	-0.5	0.97	0.42	-0.94	0.98	0.44	0.98	0.71	0.46	-0.26		0.58	0.89	0.66	0.9	0.96	0.51	0.77	-0.26	0.83	0.2	-0.23
Non Current Liabilities Total	0.7	0.14	0.9	0.6	-0.6	0.49	-0.2	-0.75	0.45	0.59	0.61	0.57	0.58	-0.37	0.58		0.21	0.83	0.85	0.45	0.65	0.04	-0.37	0.79	0.36	0.0
Other Current Assets	0.59	0.89	0.19	0.88	-0.41	0.87	0.69	-0.74	0.94	0.14	0.83	0.51	0.16	-0.06	0.89	0.21		0.38	0.66	0.87	0.21	0.96	-0.05	0.63	0.11	-0.28
Other Stockholder Equity	0.62	0.38	0.7	0.65	-0.58	0.57	0.11	-0.84	0.56	0.41	0.67	0.58	0.41	-0.67	0.66	0.83	0.38		0.78	0.54	0.48	0.29	-0.67	0.69	0.19	0.05
Total Liab	0.84	0.55	0.81	0.92	-0.66	0.84	0.18	-0.96	0.83	0.53	0.9	0.69	0.54	-0.33	0.9	0.85	0.66	0.78		0.8	0.61	0.51	-0.32	0.94	0.33	-0.16
Property Plant And Equipment Gross	0.83	0.73	0.56	0.94	-0.32	0.99	0.38	-0.85	0.97	0.45	0.96	0.71	0.48	-0.14	0.96	0.45	0.87	0.54	0.8		0.52	0.74	-0.14	0.72	0.17	-0.29
Total Current Assets	0.89	0.13	0.76	0.48	0.13	0.5	-0.44	-0.52	0.42	0.99	0.57	0.81	0.99	-0.15	0.51	0.65	0.21	0.48	0.61	0.52		0.0	-0.15	0.5	0.23	0.03
Short Term Debt	0.39	0.93	-0.04	0.76	-0.4	0.73	0.85	-0.62	0.84	-0.07	0.7	0.33	-0.05	-0.08	0.77	0.04	0.96	0.29	0.51	0.74	0.0		-0.08	0.47	-0.04	-0.16
Common Stock	-0.21	-0.18	-0.24	-0.21	0.31	-0.15	-0.09	0.49	-0.17	-0.12	-0.24	-0.22	-0.12	1.0	-0.26	-0.37	-0.05	-0.67	-0.32	-0.14	-0.15	-0.08		-0.25	0.13	-0.22
Other Liab	0.72	0.39	0.77	0.87	-0.71	0.75	0.1	-0.88	0.78	0.42	0.78	0.66	0.44	-0.26	0.83	0.79	0.63	0.69	0.94	0.72	0.5	0.47	-0.25		0.44	-0.46
Other Assets	0.24	-0.12	0.44	0.25	-0.27	0.2	-0.24	-0.23	0.15	0.24	0.16	0.38	0.24	0.13	0.2	0.36	0.11	0.19	0.33	0.17	0.23	-0.04	0.13	0.44		-0.43
Long Term Debt	-0.08	0.17	-0.22	-0.28	0.21	-0.28	0.13	0.16	-0.29	0.05	-0.13	-0.28	0.03	-0.21	-0.23	0.0	-0.28	0.05	-0.16	-0.29	0.03	-0.16	-0.22	-0.46	-0.43

Click cells to compare fundamentals

Agenus Account Relationship Matchups

Agenus fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	155.3M	214.5M	466.0M	413.6M	313.9M	329.6M
Short Long Term Debt Total	23.4M	55.7M	58.3M	78.4M	350.2M	367.8M
Other Current Liab	77.5M	92.9M	110.7M	133.2M	48.7M	28.4M
Total Current Liabilities	122.2M	129.9M	156.9M	189.0M	255.9M	268.7M
Total Stockholder Equity	(225.4M)	(203.7M)	34.4M	(61.3M)	(160.3M)	(152.3M)
Property Plant And Equipment Net	33.7M	60.3M	91.1M	164.3M	163.0M	171.2M
Net Debt	(38.4M)	(44.1M)	(233.6M)	(100.2M)	274.1M	287.8M
Retained Earnings	(1.3B)	(1.5B)	(1.5B)	(1.7B)	(2.0B)	(1.9B)
Accounts Payable	13.6M	17.0M	30.5M	40.9M	61.4M	64.5M
Cash	61.8M	99.9M	291.9M	178.7M	76.1M	71.1M
Non Current Assets Total	68.8M	100.7M	134.0M	200.4M	201.5M	211.6M
Non Currrent Assets Other	1.4M	4.1M	9.5M	4.5M	5.7M	3.5M
Cash And Short Term Investments	61.8M	99.9M	306.9M	193.4M	76.1M	81.2M
Common Stock Total Equity	1.4M	2.0M	2.6M	3.1M	2.8M	3.7M
Common Stock Shares Outstanding	135.0M	172.5M	228.9M	281.7M	357.9M	375.8M
Liabilities And Stockholders Equity	155.3M	214.5M	466.0M	413.6M	313.9M	329.6M
Non Current Liabilities Total	264.5M	296.1M	261.1M	279.5M	206.4M	113.2M
Other Current Assets	1.0M	2.0M	3.2M	3.2M	10.5M	11.0M
Other Stockholder Equity	1.0B	1.2B	1.1B	1.2B	1.5B	745.1M
Total Liab	386.7M	426.0M	418.0M	468.5M	462.3M	485.4M
Property Plant And Equipment Gross	26.3M	60.3M	141.6M	218.4M	225.0M	236.2M
Total Current Assets	86.5M	113.8M	332.0M	213.1M	112.4M	91.0M
Accumulated Other Comprehensive Income	(1.3M)	2.8M	1.5M	915K	(955K)	(1.0M)
Short Term Debt	2.0M	2.8M	3.4M	2.5M	145.7M	153.0M
Common Stock	1.4M	2.0M	2.6M	3.1M	3.9M	3.7M
Other Liab	216.1M	216.2M	205.9M	191.3M	220.0M	231.0M
Other Assets	1.4M	37.6M	9.5M	4.5M	4.0M	3.1M
Long Term Debt	13.4M	18.9M	12.8M	12.6M	12.8M	12.1M
Net Receivables	16.3M	1.2M	1.5M	2.7M	25.8M	27.1M
Good Will	23.2M	25.5M	24.9M	25.5M	24.7M	23.5M
Inventory	7.4M	10.7M	20.4M	13.8M	1.0	0.95
Intangible Assets	10.5M	10.9M	8.5M	6.2M	4.4M	8.2M
Property Plant Equipment	26.3M	60.3M	91.1M	133.0M	153.0M	160.6M
Current Deferred Revenue	29.2M	17.2M	12.4M	12.3M	18K	17.1K
Net Tangible Assets	(21.0M)	(240.0M)	1.1M	159.2M	183.1M	192.3M
Noncontrolling Interest In Consolidated Entity	(6.0M)	(7.8M)	13.5M	6.4M	7.3M	7.7M
Retained Earnings Total Equity	(1.3B)	(1.5B)	(1.5B)	(1.7B)	(1.5B)	(1.6B)
Long Term Debt Total	13.4M	18.9M	12.8M	12.6M	11.3M	10.8M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agenus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agenus' short interest history, or implied volatility extrapolated from Agenus options trading.

Pair Trading with Agenus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.

Moving against Agenus Stock

0.76	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.75	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.69	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr
0.51	HCWB	HCW Biologics	Pair Corr
0.48	KRYS	Krystal Biotech Financial Report 13th of May 2024	Pair Corr

The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.

The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:

How To Invest In Agenus

Details

Is Agenus Stock a good investment?

Details

What is Agenus' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Agenus Stock analysis

When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.

	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Money Managers Screen money managers from public funds and ETFs managed around the world

Is Agenus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(13.80)

Revenue Per Share

8.735

Quarterly Revenue Growth

1.952

Return On Assets

(0.28)

Return On Equity

(12.79)

The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agenus Selling General Administrative vs Operating Income Analysis

Selling General Administrative vs Operating Income

Selling General Administrative vs Operating Income Correlation Analysis

Correlation Coefficient

Selling General Administrative

Operating Income

Agenus fundamental ratios Correlations

Agenus Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Agenus fundamental ratios Accounts

Pair Trading with Agenus

Moving against Agenus Stock

Complementary Tools for Agenus Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Shares Outstanding	+ 0.99	Total Current Liabilities
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments

Total Liab	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Total Current Liabilities
Non Current Assets Total	- 0.93	Retained Earnings
Accounts Payable	- 0.89	Retained Earnings
Other Liab	- 0.88	Retained Earnings